Pharmafile Logo
Pharmafocus logo
Advanced Search
matthias_zachert_merck

Merck KGaA head jumping ship to Lanxess

January 29, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, Merck KGaA, lanxess, zachert

Merck KGaA’s chief financial officer Matthias Zachert is exiting the firm in order to fulfill a chief executive appointment at …

Appointment
servier image

Servier signs cancer partnership

January 29, 2014
Research and Development, Sales and Marketing AbbVie, Servier, breast cancer, curie

Servier has extended by three years its deal with leading research group Curie-Cancer to identify therapeutic targets for treating triple-negative …

News

Hikma Globalizes its Pharmacovigilance Activities together with PrimeVigilance

January 28, 2014

News
Press release
Pfizer image

Pfizer lung cancer drug suffers late-stage setback

January 28, 2014
Research and Development, Sales and Marketing Cancer, NSCLC, Pfizer, Roche, Tarceva, dacomitinib

An experimental cancer drug developed by Pfizer has failed in two separate Phase III clinical studies. Dacomitinib is a tyrosine …

News
UCB image

UCB launches online challenge to find new drugs

January 28, 2014
Medical Communications UCB, crowdsourcing, innovation challenge, website

UCB has launched its ‘Innovation Challenge’ as it looks to pay members of the public to help develop new drugs. …

News

NICE looks at Xtandi again

January 28, 2014
Sales and Marketing Astellas, NHS, NICE, Xtandi

NICE has announced it is to consult again on its decision to recommend Astellas Pharma’s prostate cancer drug Xtandi after …

News
john_p

Targacept appoints chairman

January 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept, richard

Clinical-stage biopharma firm Targecept has appointed its non-executive director since 2002 John Richard to be its chairman of the board. …

Appointment
doh image

NICE rejects ‘benefit’ test

January 28, 2014
Sales and Marketing Dillon, EMIG, NHS, NICE, benefits

NICE has refused to include a ‘wider societal benefit’ test into its deliberations about which drugs should be available on …

News

J&J: we’re proud to top social media leaderboard

January 27, 2014
Medical Communications, Sales and Marketing IMS, J&J, JJ, Janssen, digital, epatient, pharma

Johnson & Johnson says recognising the rise of the ePatient and being willing to share its corporate plans with the …

News
BMS image

BMS revenue drops in 2013

January 27, 2014
Sales and Marketing AZ, BMS, Yervoy, diabetes, hep C, q4

Bristol-Myers’ Squibb’s revenue has fallen 7% year-on-year to $16.4 billion during 2013. Turnover rose 6% to $4.4 billion in the …

News
Teva image

Teva’s Great White Hope knocked back by Europe

January 27, 2014
Sales and Marketing CHMP, EU, MS, Nerventra, Teva

The drug designed to be a follow-up to Teva’s wildly successful Copaxone has been hit by rejection in Europe, leaving …

News
nhs_parliament_2

NHS reform: did the government get it right?

January 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DH, Hunt, Lansley, NHS, atkins, reform, reforms

Some nine months after the coalition government’s controversial health reforms came in, have they been a success? And how are …

Feature
robert_j

PTC Therapeutics makes series of changes

January 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PTC Therapeutics

Biopharma firm PTC Therapeutics has expanded its senior management team with a raft of appointments. Robert Spiegel (pictured) becomes its …

Appointment
ranbaxy image

FDA extends Ranbaxy ban

January 27, 2014
Manufacturing and Production, Sales and Marketing API, FDA, Ranbaxy, toansa

India-based generic manufacturer Ranbaxy Laboratories has been dealt a further blow as the US regulator has banned more of its …

News

Shire replaces retiring chairman with former banker

January 24, 2014
Sales and Marketing Organogenesis, Shire, dermagraft, emmens, kilsby

Susan Kilsby is to be the new chairman at Shire and steps into Matthew Emmens’s role as he retires from …

News
NHS image

Elderly denied cancer treatment on NHS

January 24, 2014
Sales and Marketing Cancer, Macmillan, NCIN, NHS, elderly

A UK charity is warning the NHS not to write off older cancer patients as ‘too old’ for treatment. With …

News

Mail backs down over NICE ‘champagne perks’ attack

January 24, 2014
Medical Communications, Sales and Marketing Daily Mail, NHS, NICE, UK, spending

The Daily Mail newspaper has backed down on an article it published earlier this month, which alleged that staff at …

News

NHS consults on loosening controls for Viagra

January 23, 2014
Sales and Marketing DH, ED, NHS, Pfizer, Sildenafil, viagra

The Department of Health is looking to make cheaper generic versions of Pfizer’s Viagra more widely available to patients with …

News
Lundbeck image

Danish government: ‘Sue pharma firms’

January 23, 2014
Sales and Marketing Actavis, Danish, Denmark, Lundbeck, celexa

A senior figure in Denmark’s government has said that local authorities should take legal action against pharma firms which put …

News

Novartis may axe 1,000 jobs in Diovan wake

January 23, 2014
Manufacturing and Production, Sales and Marketing Coartem, Diovan, Novartis, cuts

Novartis will shut down a plant in New York State that made heart drug Diovan and malaria treatment Coartem as …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026